The risk of esophageal obstruction associated with an anti-allergy medication (Claritin-D 24-Hour--original formulation).
D000293:Adolescent; D000328:Adult; D000368:Aged; D000402:Airway Obstruction / Q000139:chemically induced*; D018926:Anti-Allergic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002648:Child; D003679:Deglutition; D003692:Delayed-Action Preparations; D004338:Drug Combinations; D004809:Ephedrine / Q000008:administration & dosage / Q000009:adverse effects*; D004947:Esophagus; D005260:Female; D006801:Humans; D017336:Loratadine / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D008499:Medical Records; D008875:Middle Aged; D011358:Product Surveillance, Postmarketing; D012189:Retrospective Studies
D018926:Anti-Allergic Agents; D003692:Delayed-Action Preparations; D004338:Drug Combinations; D017336:Loratadine; D004809:Ephedrine